Polymer-coated long-circulating microparticulate pharmaceuticals

Journal of Microencapsulation

Volumn 15, Issue 1, 1998, Pages 1-19

  Torchilin, V P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Drug carriers; Liposomes; Microparticles; Poly(ethylene glycol); Prolonged circulation

Indexed keywords

CYTARABINE; DOXORUBICIN; DRUG CARRIER; LIPOSOME; MACROGOL; NANOPARTICLE; POLYMER; VINCRISTINE;

CHEMICAL MODIFICATION; CIRCULATION TIME; COMPUTER ASSISTED TOMOGRAPHY; DRUG DISTRIBUTION; HUMAN; HYDROPHOBICITY; MACROMOLECULE; MICELLE; NONHUMAN; REVIEW; STEREOSPECIFICITY;

EID: 0031962780     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049809006831     Document Type: Review

References (102)

1. ALLEN, T. M., 1994, The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the manonuclear phagocyte system. Advances in Drug Delivery Reviews, 13, 285-309.
2. ALLEN, T. M., BRANDIES, E., HANSEN, C. B., KAO, G. Y., and ZALIPSKY, S., 1994, Antibody-mediated targeting of long-circulating (Stealth) liposomes. Journal of Liposome Research, 4, 1-15.
3. ALLEN, T. M., and HANSEN, C., 1991, Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochimica et Biophysica Acta, 1068, 133-141.
4. ALLEN, T. M., HANSEN, C., and RUTLEDGE, J., 1989, Liposome with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochimica et Biophysica Acta, 981, 27-35.
5. ALLEN, T. M., HANSEN, C. B., and DE MENENEZ, D. E. L., 1995, Pharmacokinetics of long-circulating liposomes. Advances in Drug Delivery Reviews, 16, 267-284.
6. ALLEN, T. M., MEHRA, T., HANSEN, C., and CHIN, Y. C., 1992, Stealth liposomes: an improved sustained release system for 1-β-D-arabinofuranosylcytosine. Cancer Research, 52, 2431-2439.
7. BADER, H., RINGSDORF, H., and SCHMIDT, B., 1984, Watersoluble polymers in medicine. Angew. Makromol. Chem., 123/124, 457-462.
8. BLUME, G., and CEVC, G., 1993, Molecular mechanism of the lipid vesicle longevity in vivo. Biochimica et Biophysica Acta, 1146, 157-168.
9. BLUME, G., CEVC, G., CROMMELIN, M. D. J. A., BAKKER-WOUDENBERG, I. A. J. M., KLUFT, C., and STORM, G., 1993, Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the end of the polymeric chains combines effective target binding with long circulaton times. Biochimica et Biophysica Acta, 1149, 180-184.
10. BLUNK, T., HOCHSTRASSER, D. F., MÜLLER, B. W., and MÜLLER, R. H., 1993, Differential adsorption: effect of plasma protein adsorption patterns on organ distribution of colloidal drug carriers. In Proceedings of the 20th International Symposium on Controlled Release Bioact. Materials (Washington: Controlled Release Society), pp. 256-257.
11. BOGDANOV, A. A., JR, WEISSLEDER, R., and BRADY, T. J., 1995, Long-circulating blood pool imaging agents. Advances in Drug Delivery Reviews, 16, 335-348.
12. BOMAN, N. L., MASIN, D., MAYER, L. D., CULLIS, P. R., and BALLY, M. B., 1994, Liposomal vincristin which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. Cancer Research, 54, 2830-2833.
13. CHONN, A., SEMPLE, S. C., and CULLIS, P. R., 1991, Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochimica et Biophysica Acta, 1070, 215-222.
14. CHONN, A., SEMPLE, S. C., and CULLIS, P. R., 1992, Association of blood proteins with large unilamellar liposomes in vivo: relation to circulation lifetimes. Journal of Biological Chemistry, 267, 18 759-18 765.
15. DES CLOIZEAUX, J., and JANNINK, G., 1990, Polymers in Solution: Their Modelling and Structure (Oxford: Clarendon).
16. COHEN, S., and BERNSTEIN, H. (eds), 1996, Microparticulate Systems for the Delivery of Proteins and Vaccines (New York: Marcel Dekker).
17. GABIZON, A., 1995, Liposome circulation time and targeting: implication for cancer chemotherapy. Advances in Drug Delivery Reviews, 16, 285-294.
18. GABIZON, A., CATANE, R., UZIELY, B., KAUFFMAN, B., SAFRA, T., COHEN, T., MARTIN, F., HAUNG, A., and BARENHOLZ, Y., 1994, Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Research, 54, 987-992.
19. GABIZON, A., and PAPAHADJOPOULOS, D., 1988, Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proceedings of the National Academy of Sciences, USA, 85, 6949-6953.
20. GABIZON, A., and PAPAHADJOPOULOS, D., 1992, The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochimica et Biophysica Acta, 1103, 94-100.
21. GOLDBERG, E. P. (ed.), 1985, Targeted Drugs (New York: John Wiley).
22. GREF, R., DOMB, A., QUELLEC, P., BLUNK, T., MULLER, R. H., VERBAVATZ, J. M., and LANGER, R., 1995, The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Advances in Drug Delivery Reviews, 16, 215-234.
23. GREF, R., MINAMITAKE, Y., PERACCHIA, M. T., TREBETSKOY, V. S., TORCHILIN, V. P., and LANGER, R., 1994, Biodegradable long-circulating polymeric nanospheres. Science, 263, 1600-1603.
24. GREGORIADIS, G., 1977, Targeting of drugs. Nature, 165, 407-411.
25. GREGORIADIS, G. (ed.), 1988, Liposomes as Drug Carriers (Avon: John Wiley).
26. GREGORIADIS, G. (ed.), 1993, Liposome Technology, vols 1-3. (Boca Raton: CRC Press).
27. HANSEN, C. B., KAO, G. Y., MOASE, E. H., ZALIPSKY, S., and ALLEN, T. M., 1995, Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochimica et Biophysica Acta, 1239, 133-144.
28. HARPER, G. R., DAVIES, M. C., DAVIS, S. S., TADROS, T. F., TAYLOR, D. C., IRVING, M. P., and WATERS, J. A., 1991, Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. Biomaterials, 12, 695-699.
29. HUANG, S. K., MAYHEW, E., GILANI, S., LASIC, D. D., MARTIN, F. J., and PAPAHADGOPOULOS, D., 1992, Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Research, 52, 6774-6781.
30. HUANG, S. K., STAUFFER, P. R., HONG, K., GUO, J. W., PHILIPS, T. L., HUANG, A., and PAPAHADJOPOULOS, D., 1994, Liposomes and hyperthermia in mice: increased tumor uptake and therapeutical efficacy of doxorubicin in sterically stabilized liposomes. Cancer Research, 54, 2186-2191.
31. HWANG, K. J., 1987, Liposome pharmacokinetics. In Liposomes: From Biophysics to Therapeutics, edited by M. Ostro (New York: Marcel Dekker), pp. 109-156.
32. ILLUM, L., and DAVIS, S. S., 1983, Effect of nonionic surfactant Poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. Journal of Pharmaceutical Science, 72, 1086-1090.
33. ILLUM, L., and DAVIS, S. S., 1984, The organ uptake of intravenously administered colloidal particles can be altered using nonionic surfactant (poloxamer 338). FEBS Letters, 167, 79-82.
34. ILLUM, L., HUNNEYBALL, I. M., and DAVIS, S. S., 1986, The effect of hydrophilic coatings on the uptake of colloidal perticles by the liver and peritoneal macrophages. International Journal of Pharmacology, 29, 53-65.
35. JAMSHAID, M., FARR, S. J., KEARNEY, P., and KELLAWAY, I. W., 1988, Poloxamer sorption on liposomes: comparison with polystyrene latex and influence on solute efflux. Interntional Journal of Pharmacology, 48, 125-131.
36. KHAW, B. A., KLIBANOV, A., O'DONNELL, S. M., SAITO, T., NOSSIFF, N., SLINKIN, M. A., NEWELL, J. B., STRAUSS, H. W., and TORCHILIN, V. P., 1991, Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. Journal of Nuclear Medicine, 32, 1742-1751.
37. KHAW, B. A., MATTIS, J. A., MELNICOFF, G., STRAUSS, H. W., GOLD, H. K., and HABER, E., 1984, Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. Hybridoma, 3, 11-23.
38. KHAW, B. A., YASUDA, T., GOLD, H. K., LEINBACH, R. C., JOHN, J. A., KANKE, M., BARLAI-KOVACH, M., STRAUSS, H. W., and HABER, E., 1987, Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab. Journal of Nuclear Medicine, 28, 1671-1678.
39. KLIBANOV, A. L., MARUYAMA, K., TORCHILIN, V. P., and HUANG, L., 1990, Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Letters, 268, 235-237.
40. KLIBANOV, A. L., MARUYAMA, K., BECKERLEG, A. M., TORCHILIN, V. P., and HUANG, L., 1991, Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochimica et Biophysica Acta, 1062, 142-148.
41. KRAUSE, H. J., SCHWARTZ, A., and ROHDEWALD, P., 1985, Polylactic acid nanoparticles, a colloidal drug delivery system for lipophilic drugs. International Journal of Pharmacology, 27, 145-155.
42. KURATA, M., and TSUNASHIMA, Y., 1989, Viscosity-molecular weight relationships and unperturbed dimensions of linear chain molecules. In Polymer Handbook, edited by J. Brandup and E. H. Himmelgut (New York: John Wiley) pp. VII/1-52.
43. KWON, G. S., SUWA, S., YOKOYAMA, M., OKANO, T., SAKURAI, Y., and KATAOKA, K., 1994, Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. Journal of Controlled Release, 29, 17-23.
44. KWON, G. S., and KATAOKA, K., 1995, Block copolymer micelles as long-circulating drig vehicles. Advances in Drug Delivery Reviews, 16, 295-309.
45. LASIC, D. D., 1993, Liposomes: From Physics to Applications (Amsterdam: Elsevier).
46. LASIC, D. D., and MARTIN, F. (eds), 1995, Stealth Liposomes (Boca Raton: CRC Press).
47. LASIC, D. D., and BARENHOLZ, Y. (eds), 1996, Handbook of Nonmedical Applications of Liposomes (Boca Raton: CRC Press).
48. M1 accumulate effectively in spleen. Biochimica et Biophysica Acta, 1066, 159-165.
49. M1-containing liposomes. Biochimica et Biophysica Acta, 1104, 95-101.
50. MARUYAMA, K., YUDA, A. O., KOJIMA, S., SUGINAKA, S., and IWATSURU, M., 1992, Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl-phosphatidylcholine and cholesterol containing amphiphatic poly(ethylene glycol). Biochimica et Biophysica Acta, 1128, 44-49.
51. MARUYAMA, K., OKUIZUMI, S., ISHIDA, O., YAMAUCHI, H., KIKUCHI, H., and IWATSURU, M., 1994, Phosphatidyl polyglycerols prolong liposome circulation in vivo. International Journal of Pharmacology, 111, 103-107.
52. MAYHEW, E. G., LASIC, D., BABBAR, S., and MARTIN, F. J., 1992, Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethyleneglycol-derivatized phospholipid. International Journal of Cancer, 51, 302-309.
53. MILNER, S. T., 1991, Polymer brushes. Science, 251, 905-907.
54. MOGHIMI, S. M., 1995, Mechanisms regulating body distribution of nanospheres conditioned with pluronic and tetronic block co-polymers. Advances in Drug Delivery Reviews, 16, 183-193.
55. MOGHIMI, S. M., PORTER, C. J. H., ILLUM, L., and DAVIS, S. S., 1991, The effect of poloxamer-407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres. International Journal of Pharmacology, 68, 121-126.
56. MOGHIMI, S. M., HEDEMAN, H., CHRISTY, N. M., ILLUM, L., and DAVIS, S. S., 1993, Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated mice. Journal of Leukocyte Biology, 54, 513-517.
57. MOGHIMI, S. M., HAWLEY, A. E., CHRISTY, N. M., GRAY, T., ILLUM, L., and DAVIS, S. S., 1994, Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Letters, 344, 25-30.
58. MOLYNEUX, P., 1997, Water-Soluble Synthetic Polymers: Properties and Behavior, vol. 2 (Boca Raton: CRC Press).
59. MONFARDINI, C., SCHIAVON, O., CALICETI, P., MORPURGO, M., HARRIS, J. M., and ERONESE, F. M., 1995, A branched monomethoxypoly(ethylene glycol) for protein modification. Bioconjugate Chemistry, 6, 62-69.
60. 1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Letters, 284, 263-266.
61. MÜLLER, R. H., 1991, Colloidal Carriers for Controlled Drug Delivery and Targeting (Stuttgart: Wissenschaftliche).
62. NAPER, D. H., 1983, Polymeric Stabilization of Colloidal Dispersions (New York: academic).
63. NEEDHAM, D., MCINTOSH, T. J., and LASIC, D. D., 1992, Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochimica et Biophysica Acta, 1108, 40-48.
64. PALMER, T. N., CARIDE, V. J., CALDECOURT, M. A., TWICKER, J., and ABDULLAH, V., 1984, The mechanism of liposome accumulation in infarction. Biochimica et Biophysica Acta, 797, 363-368.
65. PANG, S. N. J., 1993, Final report of the safety assessment of polyethylene glycols (PEGs)-6, -8, -32, -75, -150, -14M, -20M. Journal of the American College of Toxicology, 12, 429-456.
66. PATEL, H., 1992, Serum opsonins and liposomes: their interaction and opsonophagocytosis. Critical Reviews in Therapy and Drug Carrier Systems, 9, 39-90.
67. PORTER, C. J. H., MOGHIMI, S. M., ILLUM, L. L., and DAVIS, S. S., 1992, The polyethylene/polypropylene block copolymer Poloxamer-407 selectively redirects intravenously injected microspheres to sinusoial endothelial cells of rabbit bone marrow, FEBS Letters, 305, 62-66.
68. POWELL, G. M., 1980, Polyethylene glycol. In Handbook of Water Soluble Gums and Resins, edited by R. L. Davidson (New York: McGraw-Hill), chapter 18.
69. PRATTEN, M. K., LLOYD, J. B., HORPEL, G., and RINGSDORF, H., 1985, Micelle-forming block copolymers; pinocytosis by macrophages and interaction with model membranes. Macromolecular Chemistry, 186, 725-731.
70. RANUCCI, E., SPAGNOLI, G., SARTORE, L., and FERRUTI, P., 1994, Synthesis and molecular weight characterization of low molecular weight end-functionalized poly(4-acryloylmorpholine). Macromolecular Chemistry and Physics, 195, 3469-3479.
71. REVEL, D., CHAMBON, C., HAVARD, P., DANDIS, G., CANET, E., COROT, C., and AMIEL, M., 1991, Iodinated polymer as blood-pool contrast agent. Computed tomography evaluation in rabbits. Investigative Radiology, 26, S57.
72. RINGSDORF, H., 1975, Structure and properties of pharmacologically active polymers. Journal of Polymer Science, 51, 135-153.
73. SARTORE, L., RANUCCI, E., FERRUTI, P., CALICETI, P., SCHIAVON, O., and VERONESE, F. M., 1994, Low molecular weight end-functionalized poly(N-vinylpyrrolidone) for the modification of polypeptide aminogroups. Journal of Bioactive and Compatible Polymers, 9, 411-427.
74. SENIOR, J. H., 1987, Fate and behavior of liposomes in vivo: a review of controlling factors. CRC Critical Reviews in Therapeutic Drug Carrier Systems, 3, 123-193.
75. SENIOR, J., DELGADO, C., FISHER, D., TILCOCK, C., and GREGORIADIS, G., 1991, Influence of surface hydrophilicity of liposomes on their interaction with plasma proteins and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochimica et Biophysica Acta, 1062, 77-82.
76. STOLNIK, S., ILLUM, L., and DAVIS, S. S., 1995, Long circulating microparticulate drug carriers. Advances of Drug Delivery Reviews, 16, 195-214.
77. TORCHILIN, V. P., 1985, Liposomes as targetable drug carriers. CRC Critical Reviews in Therapeutic Drug Carrier Systems, 2, 65-115.
78. TORCHILIN, V. P., 1996, How do polymers prolong circulation time of liposomes. Journal of Liposome Research, 6, 99-116.
79. TORCHILIN, V. P., KLIBANOV, A. L., HUANG, L., O'DONNELL, S., NOSSIFF, N. D., and KHAW, B. A., 1992, Targeted accumulaton of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB Journal, 6, 2716-2719.
80. TORCHILIN, V. P., MILSTEIN, A. M., and SHTILMAN, M. I., 1994c, Liposome protection in vivo with synthetic polymers other than poly(ethylene glycol). In Proc. 21st Int. Symp. Control. Release Bioact. Mater. (Washington: Controlled Release Society) pp. 604-605.
81. TORCHILIN, V. P., NARULA, J., HALPERN, E., and KHAW, B. A., 1996, Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium. Biochimica et Biophysica Acta, 1279, 75-83.
82. TORCHILIN, V. P., OMELYANENKO, V. G., PAPISOV, I. M., BOGDANOV, JR, A. A., TRUBETSKOY, V. S., HERRON, J. N., and GENTRY, C. A., 1994d, Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochimica et Biophysica Acta, 1195, 11-20.
83. TORCHILIN, V. P., and PAPISOV, M. I., 1994, Why do polyethylene glycol-coated liposomes circulate so long? Journal of Liposome Research, 4, 725-739.
84. TORCHILIN, V. P., SHTILMAN, M. I., TRUBETSKOY, V. S., WHITEMAN, K., and MILSTEIN, A. M., 1994b, Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochimica et Biophysica Acta, 1195, 181-184.
85. TORCHILIN, V. P., and TRUBETSKOY, V. S., 1995, Which polymers can make nanoparticular drug carriers long-circulating? Advances in Drug Delivery Reviews, 16, 141-155.
86. TORCHILIN, V. P., TRUBETSKOY, V. S., MILSTEIN, A. M., CANNILLO, J., WOLF, G. L., PAPISOV, I. M., BOGDANOV, A. A., NARULA, J., KHAW, B. A., and OMELYANENKO, V. G., 1994a, Targeted delivery of diagnostic agents by surface-modified liposomes. Journal of Controlled Release, 28, 45-58.
87. TORCHILIN, V. P., TRUBETSKOY, V. S., PAPISOV, M. I., BOGDANOV, A. A., OMELYANENKO, V. G., NARULA, J., and KHAW, B. A., 1993, Polymer-coated immunoliposomes for delivery of pharmaceuticals: targeting and biological stability. In Proc. 20th Int. Symp. Control. Release Bioact. Mater. (Washington: Controlled Release Society) pp. 194-195.
88. TORCHILIN, V. P., TRUBETSKOY, V. S., WHITEMAN, K. R., CALICETI, P., FERRUTI, P., and VERONESE, F. M., 1995, New synthetic amphiphilic polymers for steric protection of liposomes in vivo. Journal of Pharmaceutical Science, 84, 1049-1053.
89. TRUBETSKOY, V. S., CANNILLO, J. A., MILSTEIN, A., WOLF, G. L., and TORCHILIN, V. P., 1995, Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. Magnetic Research Imaging, 13, 31-37.
90. TRUBETSKOY, V. S., FRANK-KAMENETSKY, M. D., WHITEMAN, K. R., WOLF, G. L., and TORCHILIN, V. P., 1996, Stable polymeric micelles: lymphangiographic contrast media for gamma scintigraphy and magnetic resonance imaging. Acad. Radiol., 3, 232-238.
91. TRUBETSKOY, V. S., and TORCHILIN, V. P., 1995, Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents. Advances in Drug Delivery Reviews, 16, 311-320.
92. TRUBETSKOY, V. S., and TORCHILIN, V. P., 1996, Polyethyleneglycol-based micelles as carriers of therapeutic and diagnostic agents. S.T.P. Pharma Sci., 6, 79-86.
93. TRUBETSKOY, V. S., TORCHILIN, V. P., GAZELLE, G. S., and WOLF, G. L., 1994, Amphiphilic radiopaque iodine-containing block-copolymer as micellar polymeric carrier with controlled in vivo performance. In Proceedings of the 21st International Symposium on Controlled Release of Bioactive Materials (Washington: Controlled Release Society), pp. 676-677.
94. WEISSLEDER, R., BOGDANOV, JR., A. A., NEUWELT, E. A., and PAPISOV, M., 1995, Long-circulating iron oxides for MR imaging. Advances in Drug Delivery Reviews, 16, 321-334.
95. WINSLOW, R. M., VANDEGRIFF, K. D., and INTAGLIETTA, M. (eds), 1996, Blood Substitutes: New Challenges (Boston: Birkhauser).
96. WOODLE, M. C., 1993, Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation. Chemical Physics of Lipids, 64, 249-262.
97. WOODLE, M. C., ENGBERS, C. M., and ZALIPSKY, S., 1994, New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes. Bioconj. Chem., 5, 493-496.
98. WOODLE, M. C., NEWMAN, M. S., and MARTIN, F. J., 1992, Liposome leakage and blood circulation: comparison of adsorbed block copolymers with covalent attachment of PEG. International Journal of Pharmacology, 88, 327-334.
99. YOKOYAMA, M., MIYAUCHI, M., YAMADA, N., OKANO, T., SAKURAI, Y., KATAOKA, K., and IONUE, S., 1990, Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Research, 50, 1693-1700.
100. YAMAOKA, T., TABATA, T., and IKADA, Y., 1994, Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration in mice. Journal of Pharmaceutical Science, 83, 601-606.
101. ZALIPSKY, S., 1995b, Chemistry of polyethylene glycol conjugates with biologically active molecules. Advances in Drug Delivery Reviews, 16, 157-182.
102. ZALIPSKY, S., 1995a, Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. Bioconjugate Chemistry, 6, 150-165.